Evidence map›Paper›PMID 31566073›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2019

Robust RBM3 and β-klotho expression in developing neurons in the human brain.

Travis C Jackson, Keri Janesko-Feldman, Shaun W Carlson, Shawn E Kotermanski, Patrick M Kochanek

Open access · hybridAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Chronic Kidney Disease Induces Proarrhythmic Remodeling.Circulation. Arrhythmia and electrophysiology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Travis C JacksonDepartment of Molecular Pharmacology & Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Keri Janesko-FeldmanSafar Center for Resuscitation Research, School of Medicine Children's Hospital of Pittsburgh of UPMC John G. Rangos Research Center, University of Pittsburgh, Pittsburgh, PA, USA.
Shaun W CarlsonDepartment of Neurological Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Shawn E KotermanskiDepartment of Pharmacology and Chemical Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Patrick M KochanekSafar Center for Resuscitation Research, School of Medicine Children's Hospital of Pittsburgh of UPMC John G. Rangos Research Center, University of Pittsburgh, Pittsburgh, PA, USA.
University of Pittsburgh · USChildren's Hospital of Pittsburgh · USNeurological Surgery · USUniversity of South Florida · US

Funding

The Role of RNA Binding Motif 5 in Traumatic Brain InjuryR01NS105721 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI JACKSON, TRAVIS C · 2018 to 2022
$1.6M
FGF21 Activates RBM3 and is a Novel Drug to Revolutionize Temperature ManagementR21NS098057 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JACKSON, TRAVIS C · 2017 to 2018
$427k
NINDS NIH HHS R01 NS105721NINDS NIH HHS R21 NS098057
6 · The paper itself

Abstract

RNA binding motif 3 (RBM3) is a powerful neuroprotectant that inhibits neurodegenerative cell death in vivo and is a promising therapeutic target in brain ischemia. RBM3 is increased by the hormone fibroblast growth factor 21 (FGF21) in an age- and temperature-dependent manner in rat cortical neurons. FGF21 receptor binding is controlled by the transmembrane protein β-klotho, which is mostly absent in the adult brain. We discovered that RBM3/β-klotho is unexpectedly high in the human infant vs. adult brain (hippocampus/prefrontal cortex). The use of tissue homogenates in that study precluded a comparison of RBM3/β-klotho expression among different CNS cell-types, thus, omitted key evidence (i.e. confirmation of neuronal expression) that would otherwise provide a critical link to support their possible direct neuroprotective effects in humans. This report addresses that knowledge gap. High-quality fixed human hippocampus, cortex, and hypothalamic tissues were acquired from the NIH Neurobiobank (<1 yr (premature born) infants, 1 yr, 4 yr, and 34 yr). Dual labeling of cell-type markers vs. RBM3/β-klotho revealed enriched staining of targets in neurons in the developing brain. Identifying that RBM3/β-klotho is abundant in neurons in the immature brain is fundamentally important to guide protocol design and conceptual frameworks germane to future testing of these neuroprotective pathways in humans.

Indexed as

Gene Expression RegulationAdultAnimalsBrainChild, PreschoolFemaleHumansInfantInfant, NewbornKlotho ProteinsMaleMembrane ProteinsNeuronsRatsRNA-Binding ProteinsKLB protein, humanKlotho ProteinsMembrane ProteinsRBM3 protein, humanRNA-Binding Proteinscortexdevelopmentfibroblast growth factor 21klothoRNA binding motif 3

Identifiers

PMID31566073
PMCPMC6890998
OpenAlexW2978873972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.